Business Overview: USANA Health Sciences, Inc. (NYSE: USNA)

---

Executive Summary

USANA Health Sciences, Inc. was founded in 1992 by Myron W. Wentz, Ph.D., and develops and manufactures nutritional supplements, functional foods, and personal care/skincare products, selling primarily through a global network of independent Brand Partners (formerly "Associates") in 25 geographic markets. USANA has historically operated a classic direct-selling (multi-level marketing) model, where Brand Partners earn commissions, bonuses, and retail markups on product sales and on sales generated by people they recruit.

In recent years USANA has diversified beyond its legacy "Core Nutritional" direct-selling business by acquiring majority stakes in Hiya Health (a direct-to-consumer, subscription-based children's vitamin brand) and Rise Bar/Rise Wellness (retail and e-commerce protein products), creating a second reportable segment alongside the traditional MLM business.

USANA matters to investors as a case study in both the durability and fragility of the direct-selling model: it generates high (~78%) gross margins and strong brand loyalty among its distributor base, but its legacy Core Nutritional segment has seen declining net sales and active Customers for several years, with heavy reliance on China (~41% of consolidated net sales, ~50% of core active Customers), exposing the business to Chinese direct-selling regulation and FTC scrutiny of U.S. MLM practices.

---

1. Core Business Model & How They Work

        [USANA Corporate: R&D + Manufacturing (~56% in-house)]
                           |
                           v
            [Independent Brand Partners / Preferred Customers]
                 (25 geographic markets; weekly commissions)
                           |
            +--------------+---------------+
            |                              |
            v                              v
   [Core Nutritional Sales]      [Recruitment of New Brand Partners]
   (Optimizers, Essentials,              |
    Foods, Personal Care)                v
            |                   [Commissions/Bonuses on
            v                    Downline Sales Volume]
   [Active Customers — 3-month
    purchase window] <------ Auto Order subscriptions (62% of volume)

        [Hiya Health: DTC subscription — Active Monthly Subscribers]
        [Rise Wellness: Retail + e-commerce protein products]

Brand Partners are paid weekly in most markets via commissions on personal and downline sales volume, bonuses, and contest incentives. Separately, Hiya sells kids' vitamins direct-to-consumer on a subscription model, and Rise sells protein bars and drinks through e-commerce, marketplaces, and retail — both bypassing the distributor model entirely.

---

2. Business Segments

           USANA Health Sciences (Consolidated FY2025 Net Sales: $925.3M)
                              |
        +---------------------------------------+
        |                                       |
        v                                       v
 Core Nutritional Segment              Hiya Direct-to-Consumer Segment
 (~84% of net sales, approx.)          (~16% of net sales, approx.,
  Direct-selling via Brand Partners     incl. Rise Wellness; grew from
                                         ~1% of sales in FY2024)
        |
        +-- Asia Pacific (Greater China, Southeast Asia Pacific, North Asia)
        |      China alone: ~41.3% of total net sales,
        |      ~49.9% of core nutritional active Customers
        +-- Americas and Europe

Core Nutritional remains the dominant segment and the primary profit engine, but it has been in multi-year decline, with active Customers falling to roughly 387,000 in 2025. China is both the single largest market and the single largest regulatory risk — operated through subsidiary BabyCare, which must hold province-by-province direct-selling licenses (currently Beijing, Jiangsu, Shaanxi, and Tianjin) and has not received confirmation that its model fully complies with Chinese law.

Hiya (78.85% owned, acquired December 2024) is the fastest-growing piece of the business, reaching roughly 181,700 active Monthly Subscribers and planning 2026 expansion into Canada, the U.K., and retail channels — a structurally different, non-MLM growth vector for the company.

---

3. Product Portfolio

---

4. Competitive Landscape

USANA describes its market as highly competitive with low barriers to entry, competing against direct-selling peers Amway, Herbalife, and Nu Skin, as well as e-commerce players (including Amazon) and conventional supplement retailers. Many competitors, especially Amway and Herbalife, are larger and have longer operating histories and greater resources. Hiya and Rise face a different competitive set — children's vitamin DTC brands and mainstream protein/nutrition bar brands sold at retail — markets that are even more fragmented and price-competitive.

---

5. Strategic Strengths & Risks

Strengths (moat sources):

• Science-based positioning: in-house manufacturing (~56% of products), $10.7 million of R&D spend, a patented InCelligence formulation (U.S. Patent 10,632,101), and 34 registered U.S. trademarks.
• Subscription habit formation: Auto Order accounts for 62% of direct sales product volume, creating real (if modest) consumer switching costs.
• Clean balance sheet: $158.4 million cash against only $14.0 million of debt, funding acquisitions (Hiya, Rise) without straining the company.
• Diversification beyond MLM: Hiya's subscription DTC model and Rise's retail distribution reduce reliance on a single, structurally challenged distribution channel.

Risks:

• Multi-year decline in the core business: Core Nutritional net sales and active Customers have fallen for several years; Q3 2025 produced a $6.5 million net loss on "softer-than-expected" sales tied to a new Brand Partner compensation plan, prompting a ~10% workforce reduction in October 2025.
• China concentration and regulatory risk: ~41% of net sales and ~50% of core active Customers are in China via BabyCare, which holds direct-selling licenses in only four provinces and operates under discretionary, historically unpredictable Chinese MLM regulation.
• U.S. regulatory scrutiny: the FTC issued USANA (and over 1,100 other companies) a 2021 warning letter on earnings claims and, in 2025, proposed new rulemaking requiring written substantiation of distributor earnings claims.
• Distributor/compensation-plan risk: changes to the Brand Partner compensation plan can be viewed negatively by the distributor base, and losing key Brand Partner leaders can materially affect sales — a structural fragility of the MLM model.

---

6. Financial Overview

---

7. Summary Conclusion

USANA's moat rests on a combination of intangible, science-based brand credibility within the direct-selling channel and switching costs tied to its distributor network and Auto Order subscriptions — not on scale, pricing power, or network effects, since the direct-selling market has low barriers to entry and intense competition from larger players like Amway and Herbalife. The company's pivot into Hiya and Rise is a genuine attempt to build growth engines outside the structurally challenged MLM model. The single biggest forward risk is concentration risk in China layered on top of a declining, regulation-exposed core MLM business: any adverse shift in Chinese direct-selling policy, continued Brand Partner attrition, or U.S. FTC rulemaking on earnings claims could materially impair the legacy segment faster than Hiya and Rise can offset it.